#1 🐭💓 A new preclinical study from our institute ! Aad Withaar and Laura Meems explored semaglutide in the context of #HFpEF Rudolf de Boer #MondayScientificSnack

#Semaglutide 2.4 mg reduces the risk of MACE by 20% in adults with overweight or obesity in the #SELECT trial SELECT study baseline characteristics 👇🏻 onlinelibrary.wiley.com/doi/10.1002/ob… Novo Nordisk announced the headline results from the SELECT CV outcomes trial. 👇🏻

Yes, semaglutide has beneficial effects in humans as well! Our results in preclinical HFpEF published earlier this months suggested benefit. Very pleased to see that it’s potential in humans without HFpEF. Counting off the days to ESC! Novo Nordisk Aad Withaar #cardioobesity

Frustrerend deze advertentie in LINDAmagazine over afvallen met #Semaglutide (#Ozempic). 1. Het is #medicijn, geen quick-fix 2. Game changer in obesitas 🏥 ☠️ 3. Amper leverbaar vanwege grondstof tekort Linda de Mol volgend nummer tekst en uitleg over dit nieuwe medicijn?

The word is out #ESC2023: in humans with HFpEF Semaglutide also improves Quality of Life and lowers NTproBNP. Proud that our preclinical studies could be confirmed Gamechanger ⭐️ - #cardioobesity is real!! nejm.org/doi/full/10.10… Henry Han Mikhail Kosiborod Andreas Gevaert

Weight reduction by #ozempic or #wegovy NOSJournaal. If they would have dig a bit deeper they would have realized it is a DRUG 💊. Quitting this drug without lifestyle changes = weight gain. ✅ breaking a vicious circle ❌ esthetic purposes/ lifelong therapy #doyourhomework

Just published Nature Medicine Randomized trial of tirzepatide (Mounjaro) vs placebo *after* 12 weeks of intensive lifestyle intervention and >5% weight loss nature.com/articles/s4159… At 72 weeks, Placebo group gained 2.5% weight back; GLP-1 drug lost additional 18.4% body weight

Check out this latest study performed at our lab UMCG Cardiology Research Institute ! Great example of translational research that holds potential to improve life of PLN-R14del cardiomyopathy patients Henry Han @rudolf_debar

PCHF module 8: the final module! Looking forward to learn from the giants one more time. Fun, heart failure facts and a final graduation ceremony on Saturday. Let’s get started! Cardiology USZ Solmaz Assa Mark Schuuring Arantxa Barandiaran

Thank you prof. Marc Pfeffer for your words of wisdom: “Be part of something, you cannot do it by yourself!” And that’s exactly what #PCHF has been: a 2 years course, and a life-long friendship with likeminded HFenthusiasts! #heartfailure #graduation Cardiology USZ European Society of Cardiology

#PCHF Zürich continues to set standards and lead #HeartFailure education in Europe, with a global reach. Congratulations to all of the graduates, faculty and leadership of the course - 5 generations raised, more to come! Honored to be part of this stellar family! 🎓💥🫀📚

📺Esteemed #PCHF Alumni 2022/2023, Congratulations! Your graduation marks the start of your journey as a member of our growing network dedicated to modern #HeartFailure management around the 🌍🌏🌎 heartfailurecourse.com/pchf_alumni_ma… 🙏🏽Ruta Jasaityte David Couto Mallón Massimiliano Camilli Laura Meems

Ben jij… ✅ een (bijna) arts met ambitie onzichtbaar hartfalen gemakkelijker op te sporen ✅ geïnteresseerd in de nieuwste MRI technieken en cardiologie ✅ een zelfstandige teamspeler die niet bang is om te innoveren Solliciteer dan nu! #phdstudent werkenbijumcg.nl/-/vacatures/ar…

#hartfalen in de spotlight tijdens #nationalehartfalenweek! In een interview met @hartinshape en @vrouwenhartspreekt sprak ik over hartfalen, man-vrouw verschillen én onze #hfpef poli in UMCG UMCG Cardiology Research Institute Daan Westenbrink Benieuwd naar meer? hartinshape.nl/blog/onzichtba…

Today I gave a talk at #ESC2024 about #glp1ra in #HFpEF. A fully packed room and 12 minutes to talk about new insights. What you missed? ✅ obesity is important, also for cardiologists ✅ glp1RAs are cardioprotective ✅ MoA studies are needed European Society of Cardiology HFAPresident

This morning during a combined #AHA #ACC and #ESC session at #ESC2024 I advocated for a new subspecialty of “cardiobesity”. What do you think? Yes ✅ or no 🛑?! Henry Han European Society of Cardiology Matthew MY Lee